Avidity Biosciences Stock Target Price and Analyst Consensus
| RNA Stock | USD 30.84 0.01 0.03% |
The current analyst and expert consensus on Avidity Biosciences is Strong Buy, with 7 strong buy opinions. The current projected Avidity Biosciences target price consensus is 68.27 with 11 analyst opinions. Check out Macroaxis Advice on Avidity Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.The most common way Avidity Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Avidity Biosciences executives and customers to further validate their buy or sell advice. Avidity Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Avidity Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 3.649.
Lowest Forecast 62.13 | Highest Forecast 75.78 | Target Price 68.27 |
Avidity |
It's important to approach Avidity Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Avidity Biosciences Target Price Consensus
Avidity target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Avidity Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Strong Buy |
Most Avidity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Avidity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Avidity Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAvidity Biosciences Target Price Projection
Avidity Biosciences' current and average target prices are 30.84 and 68.27, respectively. The current price of Avidity Biosciences is the price at which Avidity Biosciences is currently trading. On the other hand, Avidity Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Avidity Biosciences Market Quote on 23rd of March 2025
Target Price
Analyst Consensus On Avidity Biosciences Target Price
Avidity Biosciences Analyst Ratings
Avidity Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Avidity Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Avidity Biosciences' financials, market performance, and future outlook by experienced professionals. Avidity Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Avidity Biosciences price targets
Avidity Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Avidity Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Avidity Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Avidity Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Avidity Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Avidity Biosciences is a key component of Avidity Biosciences valuation and have some predictive power on the future returns of a Avidity Biosciences.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Plastics Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Compulsion Invested over 100 shares | |
 | Momentum Invested over 300 shares | |
 | Adviser Favorites Invested few shares | |
 | Cash Cows Invested few shares | |
 | Business Services Invested few shares | |
 | Investor Favorites Invested over 300 shares | |
 | Dividend Beast Invested over 60 shares | |
 | Driverless Cars Invested over 60 shares |
Check out Macroaxis Advice on Avidity Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Please note, the presentation of Avidity Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Avidity Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Avidity Biosciences' management manipulating its earnings.